U Lappalainen
Overview
Explore the profile of U Lappalainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stichel H, Backstrom E, Hafstrom O, Nilsson S, Lappalainen U, Bry K
Acta Paediatr
. 2011 Mar;
100(9):1206-12.
PMID: 21438921
Aim: To assess whether the levels of inflammatory and anti-inflammatory proteins in gastric fluid of premature infants shortly after birth are associated with the development of bronchopulmonary dysplasia (BPD). Methods:...
2.
Bry K, Lappalainen U
Acta Paediatr
. 2001 Mar;
90(1):74-80.
PMID: 11227339
Unlabelled: The hypothesis that endotoxin in amniotic fluid accelerates fetal lung maturation was tested. On day 25 of gestation, LPS (5 microg/fetus) was injected intra-amniotically into one uterine horn of...
3.
Uy C, Bry K, Lappalainen U, Hallman M
Pediatr Res
. 1999 Dec;
46(5):613-20.
PMID: 10541327
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic cytokine that is low in airway specimens from immature lungs at birth. In adult mice, an absence of GM-CSF causes excessive accumulation of...
4.
Cheng D, Rodriguez R, Perkett E, Rogers J, Bienvenu G, Lappalainen U, et al.
Chest
. 1999 Sep;
116(3):760-5.
PMID: 10492284
Study Objectives: The purpose of this study was to analyze the relationship of the pleural fluid vascular endothelial growth factor (VEGF) level with the diagnostic category and with the pleural...
5.
Issa A, Lappalainen U, Kleinman M, Bry K, Hallman M
Pediatr Res
. 1999 Feb;
45(2):247-54.
PMID: 10022598
Inhaled nitric oxide (iNO) is a specific pulmonary vasodilator. By serving as a pro-oxidant or antioxidant, iNO may influence other pulmonary functions as well. This study was designed to test...
6.
Hallman M, Bry K, Turbow R, Waffarn F, Lappalainen U
J Pediatr
. 1998 May;
132(5):827-9.
PMID: 9602194
We prospectively analyzed airway specimens from 24 newborn infants. Inhaled nitric oxide (< or = 20 ppm for 1 to 4 days to 12 infants) did not affect the concentrations...
7.
Hallman M, Lappalainen U, Bry K
Am J Physiol
. 1997 Jul;
273(1 Pt 1):L55-63.
PMID: 9252540
To investigate the metabolism of intra-amniotic surfactant, surfactant containing double-labeled dipalmitoylphosphatidylcholine (DPPC) was injected in amniotic fluid on days 23-27 of gestation. Within 44 h, DPPC was distributed to the...
8.
Bry K, Lappalainen U, Hallman M
J Clin Invest
. 1997 Jun;
99(12):2992-9.
PMID: 9185523
Intraamniotic infection is associated with increased IL-1 activity in amniotic fluid, increased incidence of preterm labor, and with decreased incidence of respiratory distress syndrome in infants born prematurely. We hypothesized...
9.
Dhar V, Hallman M, Lappalainen U, Bry K
Biol Neonate
. 1997 Jan;
71(1):46-52.
PMID: 8996657
Interleukin-1 (IL-1) is an important participant in infectious and inflammatory conditions. Interleukin-1 receptor antagonist (IL-1ra) prevents the effect of IL-1. We have shown that injection of interleukin-1 alpha (IL-1 alpha)...
10.
Bry K, Hallman M, Teramo K, Waffarn F, Lappalainen U
Pediatr Res
. 1997 Jan;
41(1):105-9.
PMID: 8979297
Granulocyte-macrophage colony-stimulating factor (GM-CSF), a cytokine that promotes white cell maturation, participates in the metabolism of pulmonary surfactant. Little is known on the production of GM-CSF during pregnancy or the...